{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:02:04Z","timestamp":1782932524731,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["20H03941"],"award-info":[{"award-number":["20H03941"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10067-023-06710-9","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T14:03:32Z","timestamp":1690207412000},"page":"3075-3082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia"],"prefix":"10.1007","volume":"42","author":[{"given":"Hiroyuki","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-4071","authenticated-orcid":false,"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"6710_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, De Ferranti SD, Floyd J, Fornage M et al (2017) Heart Disease and Stroke Statistics\u20192017 Update: A Report from the American Heart Association. Circulation 135:146\u2013603. https:\/\/doi.org\/10.1161\/CIR.0000000000000485","journal-title":"Circulation"},{"issue":"18","key":"6710_CR2","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971\u20131992. J Am Med Assoc 283(18):2404\u20132410. https:\/\/doi.org\/10.1001\/jama.283.18.2404","journal-title":"J Am Med Assoc"},{"key":"6710_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S1471-4892(02)00143-1","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Duk-Hee Kang RJJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811\u20131821. https:\/\/doi.org\/10.1016\/S1471-4892(02)00143-1","journal-title":"N Engl J Med"},{"key":"6710_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.amjcard.2021.05.007","volume":"152","author":"H Seki","year":"2021","unstructured":"Seki H, Kaneko H, Morita H, Itoh H, Morita K, Matsuoka S, Kiriyama H, Kamon T, Fujiu K et al (2021) Relation of Serum Uric Acid and Cardiovascular Events in Adults Aged 20\u201349 Years. Am J Cardiol 152:150\u2013157. https:\/\/doi.org\/10.1016\/j.amjcard.2021.05.007","journal-title":"Am J Cardiol"},{"issue":"3","key":"6710_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.115.06344","volume":"67","author":"RL MacIsaac","year":"2016","unstructured":"MacIsaac RL, Salatzki J, Higgins P, Walters MR, Padmanabhan S, Dominiczak AF, Touyz RM, Dawson J (2016) Allopurinol and Cardiovascular Outcomes in Adults with Hypertension. Hypertension 67(3):535\u2013540. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06344","journal-title":"Hypertension"},{"key":"6710_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fmed.2020.00063","volume":"7","author":"FS Yen","year":"2020","unstructured":"Yen FS, Hsu CC, Li HL, Wei JCC, Hwu CM (2020) Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout. Front Med 7:63. https:\/\/doi.org\/10.3389\/fmed.2020.00063","journal-title":"Front Med"},{"issue":"1","key":"6710_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6710_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D et al (2020) 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res 72(6):744\u2013760. https:\/\/doi.org\/10.1002\/acr.24180","journal-title":"Arthritis Care Res"},{"key":"6710_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1253\/CIRCJ.CJ-20-0406","volume":"85","author":"I Hisatome","year":"2021","unstructured":"Hisatome I, Li P, Miake J, Taufiq F, Mahati E, Maharani N, Utami SB, Kuwabara M, Bahrudin U et al (2021) Uric acid as a risk factor for chronic kidney disease and cardiovascular disease - Japanese guideline on the management of asymptomatic. Circ J 85:130\u2013138. https:\/\/doi.org\/10.1253\/CIRCJ.CJ-20-0406","journal-title":"Circ J"},{"issue":"1","key":"6710_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jama.2020.7848","volume":"324","author":"AR Orkaby","year":"2020","unstructured":"Orkaby AR, Driver JA, Ho YL, Lu B, Costa L, Honerlaw J, Galloway A, Vassy JL, Forman DE et al (2020) Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older. JAMA - J Am Med Assoc 324(1):68\u201378. https:\/\/doi.org\/10.1001\/jama.2020.7848","journal-title":"JAMA - J Am Med Assoc"},{"issue":"1","key":"6710_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwy201","volume":"188","author":"F Li","year":"2019","unstructured":"Li F, Thomas LE (2019) Addressing Extreme Propensity Scores via the Overlap Weights. Am J Epidemiol 188(1):250\u2013257. https:\/\/doi.org\/10.1093\/aje\/kwy201","journal-title":"Am J Epidemiol"},{"issue":"10","key":"6710_CR12","first-page":"143","volume":"45","author":"JD Seeger","year":"2007","unstructured":"Seeger JD, Kurth T, Walker AM (2007) Use of Propensity Score Technique to Account for Exposure-Related Covariates. Pharmacoepidemiol Drug Saf 45(10):143\u2013148","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"6710_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","volume":"69","author":"MC Elze","year":"2017","unstructured":"Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R, Nichols M, Stone GW, Pocock SJ (2017) Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies. J Am Coll Cardiol 69(3):345\u2013357. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.060","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"6710_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, St\u00fcrmer T (2006) Variable selection for propensity score models. Am J Epidemiol 163(12):1149\u20131156. https:\/\/doi.org\/10.1093\/aje\/kwj149","journal-title":"Am J Epidemiol"},{"key":"6710_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/eurheartj\/ehz119","volume":"40","author":"S Kojima","year":"2019","unstructured":"Kojima S, Matsui K, Hiramitsu S, Hisatome I, Waki M, Uchiyama K, Yokota N, Tokutake E, Wakasa Y et al (2019) Febuxostat for cerebral and cardiorenovascular events prevention study. Eur Heart J 40:78-1786A. https:\/\/doi.org\/10.1093\/eurheartj\/ehz119","journal-title":"Eur Heart J"},{"issue":"23","key":"6710_CR16","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","volume":"114","author":"J George","year":"2006","unstructured":"George J, Carr E, Davies J, Belch JJF, Struthers A (2006) High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114(23):2508\u20132516. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.651117","journal-title":"Circulation"},{"issue":"8","key":"6710_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4329\/wjr.v12.i8.184","volume":"12","author":"SH Barazani","year":"2020","unstructured":"Barazani SH, Chi W, Pyzik R, Chang H, Jacobi A, O\u2019Donnell T, Fayad ZA, Ali Y, Mani V (2020) Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol 12(8):184\u2013194. https:\/\/doi.org\/10.4329\/wjr.v12.i8.184","journal-title":"World J Radiol"},{"key":"6710_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1573403X14666180222102312","volume":"14","author":"S Fran\u010dula-Zaninovi\u0107","year":"2018","unstructured":"Fran\u010dula-Zaninovi\u0107 S, Nola IA (2018) Management of Measurable Variable Cardiovascular Disease\u2019 Risk Factors. Curr Cardiol Rev 14:153\u2013163. https:\/\/doi.org\/10.2174\/1573403X14666180222102312","journal-title":"Curr Cardiol Rev"},{"issue":"11","key":"6710_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4236\/ojs.2014.411088","volume":"04","author":"X Zhu","year":"2014","unstructured":"Zhu X (2014) Comparison of Four Methods for Handing Missing Data in Longitudinal Data Analysis through a Simulation Study. Open J Stat 04(11):933\u2013944. https:\/\/doi.org\/10.4236\/ojs.2014.411088","journal-title":"Open J Stat"},{"issue":"2","key":"6710_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/biostatistics\/kxl014","volume":"8","author":"PJ Rathouz","year":"2007","unstructured":"Rathouz PJ (2007) Identifiability assumptions for missing covariate data in failure time regression models. Biostatistics 8(2):345\u2013356. https:\/\/doi.org\/10.1093\/biostatistics\/kxl014","journal-title":"Biostatistics"},{"issue":"28","key":"6710_CR21","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1002\/sim.3944","volume":"29","author":"IR White","year":"2010","unstructured":"White IR, Carlin JB (2010) Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 29(28):2920\u20132931. https:\/\/doi.org\/10.1002\/sim.3944","journal-title":"Stat Med"},{"issue":"1","key":"6710_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1740774518812774","volume":"16","author":"F Yang","year":"2019","unstructured":"Yang F, Wittes J, Pitt B (2019) Beware of on-treatment safety analyses. Artic Clin TRIALS Clin Trials 16(1):63\u201370. https:\/\/doi.org\/10.1177\/1740774518812774","journal-title":"Artic Clin TRIALS Clin Trials"},{"issue":"3","key":"6710_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0197-2456(97)00145-1","volume":"19","author":"G Ch\u00eane","year":"1998","unstructured":"Ch\u00eane G, Morlat P, Leport C, Hafner R, Dequae L, Charreau I, Aboulker JP, Luft B, Aubertin J et al (1998) Intention-to-treat vs on-treatment analyses of clinical trial data: Experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. Control Clin Trials. 19(3):233\u201348. https:\/\/doi.org\/10.1016\/S0197-2456(97)00145-1","journal-title":"Control Clin Trials."},{"key":"6710_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/1471-0528.14960","volume":"125","author":"CV Ananth","year":"2018","unstructured":"Ananth CV, Schisterman EF (2018) Hidden biases in observational epidemiology: the case of unmeasured confounding. BJOG An Int J Obstet Gynaecol 125:644\u20136. https:\/\/doi.org\/10.1111\/1471-0528.14960","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"1","key":"6710_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/EDE.0b013e3181f74493","volume":"22","author":"TJ Vanderweele","year":"2011","unstructured":"Vanderweele TJ, Arah OA (2011) Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders. Epidemiology 22(1):42\u201352. https:\/\/doi.org\/10.1097\/EDE.0b013e3181f74493","journal-title":"Epidemiology"},{"issue":"4","key":"6710_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","volume":"2","author":"JL Lund","year":"2015","unstructured":"Lund JL, Richardson DB, St\u00fcrmer T (2015) The Active Comparator, New User Study Design in Pharmacoepidemiology: Historical Foundations and Contemporary Application. Curr Epidemiol Rep 2(4):221\u2013228. https:\/\/doi.org\/10.1007\/s40471-015-0053-5","journal-title":"Curr Epidemiol Rep"},{"issue":"1","key":"6710_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"ES Johnson","year":"2013","unstructured":"Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT et al (2013) The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf 22(1):1\u20136. https:\/\/doi.org\/10.1002\/pds.3334","journal-title":"Pharmacoepidemiol Drug Saf"}],"updated-by":[{"DOI":"10.1007\/s10067-024-06866-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06710-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T07:07:12Z","timestamp":1706339232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06710-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6710"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06710-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-024-06866-y","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-024-06866-y","URL":"https:\/\/doi.org\/10.1007\/s10067-024-06866-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at Kyoto University. We performed this study in accordance with the ethical standards laid out in the 1964 Declaration of Helsinki and its later amendments. The data were obtained by contract from JMDC Inc. and permission was obtained to use them in the study and to publish the results in a scientific paper. Individual consent was not needed because the data were anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Koji Kawakami has received research funds from Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Sumitomo Pharma Co., Ltd., Mitsubishi Corporation, and Real World Data Co. Ltd.; consulting fees from LEBER Inc., JMDC Inc., Shin Nippon Biomedical Laboratories Ltd., and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems, Inc.; and honoraria from Mitsubishi Corporation, Pharma Business Academy, and Toppan Inc. Other authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}